Vaginal Infections

Seven-Day Metronidazole Better for Trichomoniasis Tx in Women

October 18, 2018

Women in the seven-day-dose group less likely to be positive at test of cure versus single-dose group

First Single-Dose Oral Therapy for Bacterial Vaginosis Launched

By May 29, 2018

In both pivotal trials, a statistically significant greater percentage of treatment patients experienced clinical response vs those treated with placebo at 21 to 30 days following a single dose.

First-in-Class Antifungal Fast-Tracked for Vulvovaginal Candidiasis

By May 01, 2018

SCY-078 is an investigational antifungal agent that is a semi-synthetic derivative of the natural product enfumafungin.

CDC: Sexually Transmitted Diseases Hit 'Record High' in U.S.

By September 26, 2017

The majority of syphilis infections are seen particularly in gay, bisexual, and other men who have sex with men (MSM), of which half are also diagnosed with HIV.

Single-Dose Oral Therapy for Bacterial Vaginosis Gets Approval

By September 18, 2017

The approval was based on two randomized, placebo-controlled studies which evaluated the efficacy of Solosec in the treatment of bacterial vaginosis.

WHO: Resistance to Last-Resort Gonorrhea Tx Seen in 66% of Countries

By July 10, 2017

Gonorrhea is a sexually transmitted infection (STI) that can affect the genitals, rectum, and throat. Complications include pelvic inflammatory disease, ectopic pregnancy, infertility, and an increased risk of HIV.

Single-Dose Treatment for Bacterial Vaginosis Under Priority Review

By March 23, 2017

The FDA has accepted and granted Priority Review to the New Drug Application (NDA) of Solosec (secnidazole oral granules; Symbiomix) for the treatment of bacterial vaginosis (BV).

FDA to Review Potential Single-Dose Therapy for Bacterial Vaginosis

By January 19, 2017

Symbiomix announced the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Solosec (secnidazole oral granules) for the treatment of bacterial vaginosis (BV).

Suppression of HSV-2 Shedding Compared for Pritelivir, Valacyclovir

By December 20, 2016

Data from a randomized, double-blind clinical study found that the use of pritelivir led to a lower percentage of swabs with herpes simplex virus (HSV) detection over 28 days vs. valacyclovir. Full findings from the study are published in JAMA.

Pregnancy and Probiotics: Is There a Benefit?

November 01, 2016

For pregnant women, probiotics have no effect on vaginal health, according to a study published in the November issue of the American Journal of Obstetrics & Gynecology.

New Molecular Test Cleared to Detect Vaginitis Causes

By October 31, 2016

BD announced that the Food and Drug Administration (FDA) has granted marketing clearance for BD MAX Vaginal Panel to detect the most common causes for vaginitis.

Positive Results for Potential Bacterial Vaginosis Treatment Announced

By May 26, 2016

Symbiomix announced positive results from the second pivotal Phase 3 trial of SYM-1219 (secnidazole) for the treatment of bacterial vaginosis (BV).

CDC: Hep C Tops Infectious Disease Mortality in the U.S.

May 05, 2016

The number of hepatitis C-linked deaths in the United States reached a record high in 2014, and the disease is now the leading cause of infectious disease mortality in the United States.

Efficacy of Azithromycin in Chlamydia Examined

December 29, 2015

Although study did not establish noninferiority of azithromycin versus doxycycline

Novel Antibiotic Fast Tracked for Bacterial Vaginosis

By August 27, 2015

The Food and Drug Administration (FDA) has granted SYM-1219 (secnidazole, Symbiomix) Fast Track designation for the treatment of bacterial vaginosis (BV).

Variations Seen in Group B Strep Testing, Prophylaxis By Obstetricians

July 31, 2015

Almost all obstetricians collect group B streptococcus screening samples, but practice patterns vary.

2009 Pap Guidelines Linked to Drop in Chlamydia Testing

July 22, 2015

A major change in Papanicolaou (Pap) test guidelines introduced in 2009 may have had an unintended consequence: Some young women are missing out on screening for chlamydia.

Treatment, Management of STDs Updated in CDC Guidelines

June 08, 2015

New recommendations have been provided to update the 2010 guidelines on the treatment and management of sexually transmitted diseases (STDs).

Are Women Being Overscreened for Some STIs?

January 05, 2015

For urban women ages 25 years and older, the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is low, and women may be overscreened.

Chlamydia, Gonorrhea Cases Down But Syphilis Rates Up

By December 17, 2014

The Centers for Disease Control and Prevention (CDC) has released its annual fact sheet of the three reported sexually transmitted diseases (STDs): chlamydia, gonorrhea, and syphilis.

Vitamin D May Not Prevent Repeat Vaginosis Episodes

October 29, 2014

A new study suggests that high doses of vitamin D may not help prevent the return of bacterial vaginosis (BV).

Nearly 2 Million Women Infected with Chlamydia, But Many Unaware

September 26, 2014

An estimated 1.8 million Americans aged 14-39 are infected with Chlamydia trachomatis, and many don't know it.

Monistat Introduces Complete Care Products Line

July 09, 2014

Monistat announced the launch of Monistat Complete Care products, which include a vaginal health test, probiotics, and an odor-neutralizing gel.

Many Chlamydia Infections Go Undiagnosed

June 11, 2014

About 400,000 Americans may have the sexually transmitted disease chlamydia, but not know they have it, new research suggests.

Over Two-Thirds of U.S. Infected with HPV

May 20, 2014

A new study has found that 69% percent of healthy American adults are infected with one or more of 109 strains of the human papillomavirus (HPV).

New Preconception Test to Detect Vaginal Infections

May 07, 2014

e.p.t. announced the launch of its Preconception Health Test, a new test that measures vaginal acidity and indicates the presence of infections so women can seek treatment before trying to conceive.

Hormones, Vaginal Flora Impact Cervicovaginal Lavage

April 01, 2014

Hormonal contraception use and vaginal flora all impact the properties of cervicovaginal lavage.

FDA OK's High-Dose Metronidazole Vaginal Gel

March 26, 2014

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis.

Pritelivir Safe, Effective for Genital HSV-2 Infection

January 16, 2014

Pritelivir is safe and effective for treatment of genital herpes simplex virus (HSV)-2 infection.

Fewer Opioid Treatment Centers Offering HIV, STI Testing

December 30, 2013

For-profit centers, which increased in number from 2000 to 2011, saw greatest testing declines.